Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Clin Lung Cancer. 2018 Jan;19(1):e85-e90. doi: 10.1016/j.cllc.2017.05.022. Epub 2017 Jun 8.
The aim of this study was to determine the prognostic factors of radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT).
A total of 50 patients (36 male and 14 female) were treated with SBRT for 42 primary lung cancers and 8 metastatic lung cancers. SBRT was performed with 48 Gy in 4 fractions to the isocenter or with 40 Gy in 4 fractions covering 95% of the planning target volume. Percentage of low attenuation area (%LAA) was defined as percentage of the lung area with attenuation of -860 Hounsfield units (HU) or lower (%LAA-860) or of -960 HU or lower (%LAA-960). The dosimetric parameter of V, which means percentage volume of the lung receiving 20 Gy or more, was recalculated. RP was assessed using Common Terminology Criteria for Adverse Events version 4.0.
The median follow-up period was 39.0 months (range, 7.2-94.5 months). RP of Grade 0, Grade 1, and Grade 2 to 3 was diagnosed in 11, 29, and 10 patients, respectively. Multivariate analyses (MVA) for Grade 1 showed that higher %LAA-860 and higher %LAA-960 were significantly associated with a lower rate of Grade 1 RP. MVA for Grade 2 to 3 showed that lower Brinkman index and lower lung V were significantly associated with a lower rate of Grade 2 to 3 RP, and, in contrast, %LAA-860 and %LAA-960 had no association with Grade 2 to 3 RP.
This result suggests that high %LAA is associated with radiological changes (Grade 1) but that %LAA has no correlation with Grade 2 to 3 RP because symptomatic RP might also be affected by other factors.
本研究旨在确定立体定向体放射治疗(SBRT)后放射性肺炎(RP)的预后因素。
共有 50 例患者(36 例男性和 14 例女性)接受 SBRT 治疗 42 例原发性肺癌和 8 例转移性肺癌。SBRT 采用 48 Gy/4 次分割或 40 Gy/4 次分割,覆盖计划靶区的 95%。低衰减面积百分比(%LAA)定义为衰减值为-860 亨氏单位(HU)或更低的肺面积百分比(%LAA-860)或衰减值为-960 HU 或更低的肺面积百分比(%LAA-960)。重新计算 V 等剂量参数,即表示肺接受 20 Gy 或更多剂量的体积百分比。采用通用不良事件术语标准 4.0 评估 RP。
中位随访时间为 39.0 个月(范围,7.2-94.5 个月)。分别有 11、29 和 10 例患者诊断为 RP 0 级、1 级和 2-3 级。1 级的多变量分析(MVA)显示,较高的%LAA-860 和较高的%LAA-960 与 1 级 RP 发生率较低显著相关。2-3 级的 MVA 显示,较低的布赖克曼指数和较低的肺 V 与 2-3 级 RP 发生率较低显著相关,而%LAA-860 和%LAA-960 与 2-3 级 RP 无显著相关性。
该结果表明,高%LAA 与放射性改变(1 级)相关,但%LAA 与 2-3 级 RP 无相关性,因为有症状的 RP 也可能受到其他因素的影响。